| Evaluation of abnormal liver-enzyme results in asymptomatic patients DS Pratt, MM Kaplan New England Journal of Medicine 342 (17), 1266-1271, 2000 | 1718 | 2000 |
| Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure AA Demetriou, RS Brown Jr, RW Busuttil, J Fair, BM McGuire, ... Annals of surgery 239 (5), 660-670, 2004 | 820 | 2004 |
| Clinical best practice advice for hepatology and liver transplant providers during the COVID‐19 pandemic: AASLD expert panel consensus statement OK Fix, B Hameed, RJ Fontana, RM Kwok, BM McGuire, DC Mulligan, ... Hepatology 72 (1), 287-304, 2020 | 454 | 2020 |
| Ipilimumab-associated hepatitis: clinicopathologic characterization in a series of 11 cases M Johncilla, J Misdraji, DS Pratt, AT Agoston, GY Lauwers, A Srivastava, ... The American journal of surgical pathology 39 (8), 1075-1084, 2015 | 206 | 2015 |
| Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial JR Allegretti, Z Kassam, M Carrellas, BH Mullish, JR Marchesi, ... Official journal of the American College of Gastroenterology| ACG 114 (7 …, 2019 | 201 | 2019 |
| Liver transplantation outcomes for early‐stage hepatocellular carcinoma: results of a multicenter study JY Leung, AX Zhu, FD Gordon, DS Pratt, A Mithoefer, K Garrigan, ... Liver Transplantation 10 (11), 1343-1354, 2004 | 187 | 2004 |
| IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material V Deshpande, NI Sainani, RT Chung, DS Pratt, G Mentha, ... Modern Pathology 22 (10), 1287-1295, 2009 | 167 | 2009 |
| Aerobic capacity is associated with 100‐day outcome after hepatic transplantation SK Epstein, RB Freeman, A Khayat, JN Unterborn, DS Pratt, MM Kaplan Liver Transplantation 10 (3), 418-424, 2004 | 154 | 2004 |
| The Impact of Cirrhosis on CD4+ T Cell Counts in HIV-Seronegative Patients BH McGovern, Y Golan, M Lopez, D Pratt, A Lawton, G Moore, M Epstein, ... Clinical Infectious Diseases 44 (3), 431-437, 2007 | 148 | 2007 |
| Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis MG Amin, MP Wolf, JA TenBrook Jr, RB Freeman Jr, SJ Cheng, DS Pratt, ... Liver transplantation 10 (12), 1468-1475, 2004 | 139 | 2004 |
| The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine DS Pratt, DP Flavin, MM Kaplan Gastroenterology 110 (1), 271-274, 1996 | 137 | 1996 |
| Living-Donor Versus Cadaveric Liver Transplantation for Non-Resectable Small Hepatocellular Carcinoma and Compensated Cirrhosis: A Decision Analysis1 SJ Cheng, DS Pratt, RB Freeman Jr, MM Kaplan, JB Wong Transplantation 72 (5), 861-868, 2001 | 120 | 2001 |
| A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA JM Schattenberg, A Pares, KV Kowdley, MA Heneghan, S Caldwell, ... Journal of hepatology 74 (6), 1344-1354, 2021 | 114 | 2021 |
| Liver chemistry and function tests DS Pratt Sleisenger and fordtran's gastrointestinal and liver disease, 1227-1237. e2, 2010 | 113 | 2010 |
| Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis T Mueller, C Beutler, AH Picó, O Shibolet, DS Pratt, A Pascher, ... Liver International 31 (10), 1574-1588, 2011 | 108 | 2011 |
| Tamoxifen-induced steatohepatitis DS Pratt, TA Knox, J Erban Annals of Internal Medicine 123 (3), 236, 1995 | 106 | 1995 |
| Long‐term clinical impact and cost‐effectiveness of obeticholic acid for the treatment of primary biliary cholangitis S Samur, M Klebanoff, R Banken, DS Pratt, R Chapman, DA Ollendorf, ... Hepatology 65 (3), 920-928, 2017 | 102 | 2017 |
| A novel histological lesion in glucocorticoid-responsive chronic hepatitis DS Pratt, KA Fawaz, A Rabson, R Dellelis, MM Kaplan Gastroenterology 113 (2), 664-668, 1997 | 91 | 1997 |
| Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients P Yachimski, DS Pratt Journal of clinical gastroenterology 42 (2), 178-190, 2008 | 89 | 2008 |
| Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study KV Kowdley, TD Trainer, JR Saltzman, M Pedrosa, EL Krawitt, TA Knox, ... Gastroenterology 113 (4), 1270-1277, 1997 | 88 | 1997 |
